Curative Biotechnology Inc (CUBT) Financials

$0.75

$0.04 (6.23%)

As on 04-Sep-2026 10:35EDT

Market cap

$8 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.09	0.09	0.09	0.10	0.01	0.01
Gross Profit	-0.09	-0.09	-0.09	-0.10	-0.01	-0.01
Operating Expenses	1.14	1.41	2.35	1.84	4.44	5.00
Operating Profit (EBIT)	-1.23	-1.50	-2.44	-1.93	-4.47	-5.01
Other Income	--	--	--	--	--	--
Profit before Tax	-2.03	-2.26	-3.57	-3.96	-5.38	-5.34
Provision for Tax	--	--	--	0.00	1.18	0.18
Profit after Tax (Net Income)	-2.03	-2.26	-3.57	-3.96	-5.38	-5.34
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-18.82

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-6.39	-6.09	-4.91	-3.14	-2.54	1.68
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	18.13	18.04
Current Liabilities	8.55	8.20	7.08	5.75	4.60	0.73
Total Liabilities	10.71	2.11	2.16	2.60	2.09	2.41

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1.96	2.00	1.95	2.00	2.02	1.66
Current Assets	0.20	0.11	0.21	0.60	0.07	0.75
Total Assets	2.36	2.11	2.16	2.60	2.09	2.41
Total Debt*	1.36	1.36	1.37	2.26	1.07	--
Net Current Assets	--	--	--	--	-4.42	0.02

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-0.87	-1.02	-0.49	-1.54	-1.60
Cash Flow from Investing Activities	--	--	--	-0.01	-0.08	-0.02
Cash from Financing Activities	--	0.89	0.99	0.50	1.00	2.14
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.28	-0.32	0.00	0.00	-0.01	-0.02
Cash EPS ($)	--	-0.32	0.00	0.00	-0.01	-0.02
Adjusted Book Value ($)	--	--	--	--	--	0.00
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.12	0.00	0.00	0.00	0.00
Free Cash Flow per Share ($)	--	-0.12	0.00	0.00	0.00	0.00

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	54.71	161.02	336.49	-5,025.29	468.41
ROE (%)	--	41.15	88.51	139.31	1,256.23	376.08
ROA (%)	-89.13	-105.94	-149.58	-168.66	-239.04	-227.90
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	40.93	38.45	6.13	41.74	13.59	-12.17
Net Profit Growth (%)	31.69	36.52	9.91	26.45	-0.75	-14.35
EPS Growth (%)	-159.47	-80.60	0.11	0.53	0.41	-0.12
Book Value Growth (%)	2.21	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.02	-3.30	-4.86	-2.15	-3.31
Price / Book Value	--	-0.01	-2.40	-6.12	-4.56	10.52
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.88	-0.96	-5.59	-8.57	-2.89	-3.30
Close Price ($)	1.20	0.01	0.01	0.02	0.02	8,320.00
High Price ($)	1.99	0.03	0.04	0.03	13,280.00	35,120.00
Low Price ($)	0.00	0.00	--	--	0.00	4,352.00
Market Cap ($ Cr)	8.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.22	-0.28	-0.72	-0.42	--
Short term debt to equity ratio	-0.21	-0.22	-0.28	-0.72	-0.44	--
Current Ratio	0.02	0.01	0.03	0.11	0.01	1.03
Quick Ratio	0.02	--	--	0.13	--	--
Interest Coverage	-1.12	-1.50	-2.17	-1.92	-4.86	-29.23

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	-457.98	-433.08	--	--
Payable days	--	17,158.30	15,079.35	12,961.84	95,516.11	22,333.49
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.